PPT Slide

SPECIFIC INDICATIONS (2) :

1. levofloxacin 500 mg q12h IV

2. association with neomacrolide IV

Subgroup 3

Clinical failure after 3 days of beta-lactams (cover atypicals).

Previous slide

Next slide

Back to first slide

View graphic version